Jan 09, 2023 / 06:30PM GMT
Eric William Joseph - JPMorgan Chase & Co, Research Division - VP & Senior Analyst
Okay. We'll get started. I'm Eric Joseph, Senior Biotech Analyst with JPMorgan. Our next presenting company is C4 Therapeutics and presenting on behalf of the company CEO, Andrew Hirsch. We'll be doing Q&A after the presentation in the room and for those viewing on the digital conference book, feel free to submit questions via the portal. So with that, Andrew.
Andrew J. Hirsch - C4 Therapeutics, Inc. - CEO, President & Director
Great. Thanks, Eric, and thanks for JPMorgan for having us here today. It's very exciting to actually be here in person and not presenting from my living room, which we did last year. I'm really excited to provide an update on the progress we've made at C4 Therapeutics over the past year, and we have upcoming in store for 2023.
But before I begin, I'll be making forward-looking statements, and this is our disclaimer on that matter, subject to risks and uncertainties that are outlined in the risk factors in our SEC statement. So C4
C4 Therapeutics Inc at JPMorgan Healthcare Conference Transcript
Feb 06, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers